Sponsored Links
  • Abbott 1300x380
  • ODI Orthodynamics Company 1300x380
  • EigenFlow 2 Advanced 1300x380
  • Grifols 1300x380
  • Medtronic 1300x380
  • VitalGo Systems 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation

Medical Perfusion
Industry News

Reviewing The Evolution Of Simulation-Based Training To Create A Safer Future

In June 2022, researchers from the Rutgers School of Health Professions, Department of Interdisciplinary Studies, looked at the history of simulation-based training and reviewed its current applications with the goal of providing a foundation for future developments and expanded use. The complete manuscript by Jared Bienstock and Albert Heuer can be found in Medicine. A summary…


A Review Of Impella As An Unloading Strategy During VA-ECMO

In December 2021, researchers from Harefield Hospital, Department of Cardiology, and Imperial College, Cardiovascular Sciences, investigated the safety and efficacy of Impella for LV unloading during ECMO in patients experiencing a cardiogenic shock. The full manuscript by Francesca Fiorelli and Vasileios Panoulas can be found in Reviews in Cardiovascular Medicine. In addition, a summary of the…


Current Guidelines For Cardiopulmonary Resuscitation

In August 2022, Adult Congenital Heart Disease researchers at Southampton University Hospital summarized current guidelines on cardiopulmonary resuscitation as provided by the Resuscitation Council UK. The complete summary by Panagiota Mitropoulou and Samantha Fitzsimmons can be found in Medicine. Their key points are detailed below. Cardiac arrest occurs when cardiac activity suddenly stops, causing the affected…


Obstacles Surrounding The Expansion Of TAVR Use

In July 2022, researchers from the University Medical Center Schleswig-Holstein (Departments of Cardiovascular Surgery, Internal Medicine III (Cardiology, Angiology, and Critical Care), and Radiology and Neuroradiology), German Centre for Cardiovascular Research, Centre for Heart Lung Innovation & Providence Research, Centre for Cardiovascular Innovation, Centre for Heart Valve Innovation, Centre for Heart Lung Innovation, St. Paul’s…


A Review Of Anticoagulant Options For Pediatric Patients On ECMO

In July 2022, researchers from Columbia University Medical Center (Department of Pediatrics), Children’s Hospital of Michigan (Division of Hematology), and Erasmus Medical Center University Medical Center Sophia Children’s Hospital (Department of Pediatric Hematology and Oncology) reviewed the use of unfractionated heparin (UFH) and direct thrombin inhibitors (DTIs) in pediatric patients with extracorporeal membrane oxygenation (ECMO)…


Outcomes for Left Ventricular Assist Device Usage with End-Stage Renal Disease

In April 2022, researchers from Queens Hospital Center (Internal Medicine), Icahn School of Medicine at Mount Sinai (Internal Medicine), Kettering Medical Center (Internal Medicine), Rawal Institute of Health Services (Medicine), Weill Cornell Medicine (Cardiology/Medicine), and Queens Hospital Center (Cardiology) examined the outcomes of end-stage renal disease (ESRD) patients requiring a left ventricular assist device (LVAD)…


Determining the Metabolites Removed by CRRT

In November 2022, researchers from the First and Second Affiliated Hospital of Harbin Medical University (Department of Intensive Care Medicine) completed a prospective study screening differential metabolic markers in AKI patients before and after CRRT to determine which are removed. The complete study by Yue Li, Wenhua Liu, Kaijiang Yu, Hongliang Wang, and Changsong Wang…


Current Data on Minimalist TAVR Care Pathways and Future Research Directions

In June 2022, researchers from Emory University School of Medicine, Division of Cardiology, Department of Internal Medicine, and Division of Cardiothoracic Surgery summarized current data for a minimalist TAVR approach and what future studies need to focus on to optimize TAVR care. The full manuscript by Mariem A. Sawan, Avery E. Calhoun, Kendra J. Grubb,…


Overcoming Complications of Cardiovascular Prevention in Diabetic Patients Through Aspirin

In March 2022, researchers from Université de Montréal (Faculties of Pharmacy and Medicine), Montreal Heart Institute (Department of Medicine and Research Center), and the Institut de Recherche Clinique de Montréal completed a review on the use of aspirin in patients with diabetes and its effect to prevent cardiovascular diseases. The complete manuscript by Mélina Del Bianco-Rondeau,…


Simultaneous Use of Percutaneous Aspiration (AngioVac) and Transcatheter Mitral Valve-in-Valve Intervention for Mitral Valve Vegetation

In July 2022, medical professionals from the University of Arkansas for Medical Sciences reported a case of mitral valve bioprosthesis failure due to significant vegetation successfully treated with percutaneous aspiration (AngioVac) evacuation followed by MViV intervention. The complete report by Jack Xu, Shravan Turaga, Jay Bhama, Srikanth Vallurupalli, and Gaurav Dhar can be found in…


Updated Guidelines on The Perioperative Management of Diabetes

In January 2022, The Royal London Hospital clinicians provided guidance on perioperative management of diabetes to reduce postoperative complications. The complete manuscript by Bonnie Grant and Tahseen A. Chowdhury can be found in Clinical Medicine. Its summary is described below. Surgical intervention is more likely in those with diabetes than those without it. In addition,…


Medical Education and Training Within Congenital Cardiology

In February 2022, researchers from Children’s Health Ireland at Crumlin (Department of Paediatric Cardiology), University College Dublin, The Heart Institute at Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine (Department of Pediatrics), East Midlands Congenital Heart Centre (Department of Pediatric Cardiology), Red Cross War Memorial Children’s Hospital (Division of Paediatric Cardiology), Groote…


Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.